Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R O'Brien

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Anti-Cancer Drugs|November 29, 2007
Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancerMary E R O'Brien
Lung Cancer (Amsterdam, Netherlands)|July 21, 2004
Malignant mesothelioma--the UK experienceMary E R O'Brien
Seminars in Interventional Cardiology : SIIC|February 15, 2001
Pathophysiological insights from studies of retrieved coronary atherectomy tissueC Glover, E R O'Brien
Canadian Journal of Physiology and Pharmacology|August 5, 2003
Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activityYong-Xiang Chen, E R O'Brien
Canadian Family Physician Medecin De Famille Canadien|January 14, 2011
Practical Approach to Syncope: Identifying causes and underlying conditionsE R O'Brien, A S Tang
Trends in Cardiovascular Medicine|January 20, 2011
Update on the biology and clinical study of restenosisE R O'Brien, S M Schwartz
European Journal of Cancer (Oxford, England : 1990)|March 29, 2013
The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancerTanja Cufer, Mary E R O'Brien
British Journal of Cancer|August 22, 2002
The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE)J S Waters, M E R O'Brien
Expert Review of Anticancer Therapy|June 9, 2007
Topotecan for the treatment of small-cell lung cancerShibani J Nicum, Mary E R O'Brien
The Journal of Invasive Cardiology|September 5, 2001
Acute outcome with the flexicut directional coronary atherectomy catheter for the treatment of coronary in-stent restenosisE R O'Brien, C Glover, M Labinaz
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Anti-Cancer Drugs|November 29, 2007
Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancerMary E R O'Brien
Lung Cancer (Amsterdam, Netherlands)|July 21, 2004
Malignant mesothelioma--the UK experienceMary E R O'Brien
Seminars in Interventional Cardiology : SIIC|February 15, 2001
Pathophysiological insights from studies of retrieved coronary atherectomy tissueC Glover, E R O'Brien
Canadian Journal of Physiology and Pharmacology|August 5, 2003
Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activityYong-Xiang Chen, E R O'Brien
Canadian Family Physician Medecin De Famille Canadien|January 14, 2011
Practical Approach to Syncope: Identifying causes and underlying conditionsE R O'Brien, A S Tang
Trends in Cardiovascular Medicine|January 20, 2011
Update on the biology and clinical study of restenosisE R O'Brien, S M Schwartz
European Journal of Cancer (Oxford, England : 1990)|March 29, 2013
The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancerTanja Cufer, Mary E R O'Brien
British Journal of Cancer|August 22, 2002
The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE)J S Waters, M E R O'Brien
Expert Review of Anticancer Therapy|June 9, 2007
Topotecan for the treatment of small-cell lung cancerShibani J Nicum, Mary E R O'Brien
The Journal of Invasive Cardiology|September 5, 2001
Acute outcome with the flexicut directional coronary atherectomy catheter for the treatment of coronary in-stent restenosisE R O'Brien, C Glover, M Labinaz
Pageof 11